Literature DB >> 28130445

Interferon-inducible LY6E Protein Promotes HIV-1 Infection.

Jingyou Yu1,2, Chen Liang3,4, Shan-Lu Liu5,6.   

Abstract

LY6E is a glycosylphosphatidylinositol-anchored, IFN-inducible protein that regulates T lymphocytes proliferation, differentiation, and development. Single-nucleotide polymorphism rs2572886 in the LY6 family protein locus has been shown to associate with accelerated progression to AIDS. In this study, we show that LY6E promotes HIV, type 1 (HIV-1) infection by enhancing viral entry and gene expression. Knockdown of LY6E in human peripheral blood mononuclear, SupT1, and THP-1 cells diminishes HIV-1 replication. Virion-cell and cell-cell fusion experiments revealed that LY6E promotes membrane fusion of the viral entry step. Interestingly, we find that LTR-driven HIV-1 gene expression is also enhanced by LY6E, suggesting additional roles of LY6E in HIV-1 replication. HIV-1 infection induces LY6E expression in human peripheral blood mononuclear cells, concomitant with increased production of type I IFN and some classical IFN-stimulated genes. Altogether, our results demonstrate that IFN-inducible LY6E promotes HIV-1 entry and replication and highlight a positive regulatory role of IFN-induced proteins in HIV-1 infection. Our work emphasizes the complexity of IFN-mediated signaling in HIV-host interaction and AIDS pathogenesis.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  HIV; IFN-stimulated genes; LY6E; gene expression; lymphocyte; membrane fusion; virus entry

Mesh:

Substances:

Year:  2017        PMID: 28130445      PMCID: PMC5377782          DOI: 10.1074/jbc.M116.755819

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.

Authors:  Xuebing Feng; Hui Wu; Jennifer M Grossman; Punchong Hanvivadhanakul; John D FitzGerald; Grace S Park; Xin Dong; Weiling Chen; Michelle H Kim; Haoling H Weng; Daniel E Furst; Alan Gorn; Maureen McMahon; Mihaela Taylor; Ernest Brahn; Bevra H Hahn; Betty P Tsao
Journal:  Arthritis Rheum       Date:  2006-09

2.  Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus.

Authors:  Xuebing Feng; Jing Huang; Yan Liu; Lihui Xiao; Dandan Wang; Bingzhu Hua; Betty P Tsao; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2014-10-26       Impact factor: 2.980

3.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  The major locus for mouse adenovirus susceptibility maps to genes of the hematopoietic cell surface-expressed LY6 family.

Authors:  Katherine R Spindler; Amanda R Welton; Efrem S Lim; Suman Duvvuru; Irene W Althaus; Jennifer E Imperiale; Adam I Daoud; Elissa J Chesler
Journal:  J Immunol       Date:  2010-02-17       Impact factor: 5.422

5.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

6.  Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro.

Authors:  John W Schoggins; Marcus Dorner; Michael Feulner; Naoko Imanaka; Mary Y Murphy; Alexander Ploss; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

7.  Increased expression of the type I interferon-inducible gene, lymphocyte antigen 6 complex locus E, in peripheral blood cells is predictive of lupus activity in a large cohort of Chinese lupus patients.

Authors:  J Tang; Y Gu; M Zhang; S Ye; X Chen; Q Guo; J Qian; C Bao; S Chen; N Shen
Journal:  Lupus       Date:  2008-09       Impact factor: 2.911

Review 8.  Interferon-stimulated genes and their antiviral effector functions.

Authors:  John W Schoggins; Charles M Rice
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

9.  The glycosyl phosphatidylinositol anchor is critical for Ly-6A/E-mediated T cell activation.

Authors:  B Su; G L Waneck; R A Flavell; A L Bothwell
Journal:  J Cell Biol       Date:  1991-02       Impact factor: 10.539

10.  IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.

Authors:  Jingyou Yu; Minghua Li; Jordan Wilkins; Shilei Ding; Talia H Swartz; Anthony M Esposito; Yi-Min Zheng; Eric O Freed; Chen Liang; Benjamin K Chen; Shan-Lu Liu
Journal:  Cell Rep       Date:  2015-09-17       Impact factor: 9.423

View more
  16 in total

1.  CD4-Dependent Modulation of HIV-1 Entry by LY6E.

Authors:  Jingyou Yu; Chen Liang; Shan-Lu Liu
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

Review 2.  The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2.

Authors:  Saba R Aliyari; Natalie Quanquin; Olivier Pernet; Shilei Zhang; Lulan Wang; Genhong Cheng
Journal:  Pathogens       Date:  2022-05-03

3.  LY6S, a New IFN-Inducible Human Member of the Ly6a Subfamily Expressed by Spleen Cells and Associated with Inflammation and Viral Resistance.

Authors:  Moriya Shmerling; Michael Chalik; Nechama I Smorodinsky; Alan Meeker; Sujayita Roy; Orit Sagi-Assif; Tsipi Meshel; Artem Danilevsky; Noam Shomron; Shmuel Levinger; Bar Nishry; David Baruchi; Avital Shargorodsky; Ravit Ziv; Avital Sarusi-Portuguez; Maoz Lahav; Marcelo Ehrlich; Bryony Braschi; Elspeth Bruford; Isaac P Witz; Daniel H Wreschner
Journal:  Immunohorizons       Date:  2022-04-19

4.  LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step.

Authors:  Katrina B Mar; Nicholas R Rinkenberger; Ian N Boys; Jennifer L Eitson; Matthew B McDougal; R Blake Richardson; John W Schoggins
Journal:  Nat Commun       Date:  2018-09-06       Impact factor: 14.919

Review 5.  Relating GPI-Anchored Ly6 Proteins uPAR and CD59 to Viral Infection.

Authors:  Jingyou Yu; Vaibhav Murthy; Shan-Lu Liu
Journal:  Viruses       Date:  2019-11-14       Impact factor: 5.048

Review 6.  Emerging Role of LY6E in Virus-Host Interactions.

Authors:  Jingyou Yu; Shan-Lu Liu
Journal:  Viruses       Date:  2019-11-03       Impact factor: 5.048

7.  LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.

Authors:  Xuesen Zhao; Shuangli Zheng; Danying Chen; Mei Zheng; Xinglin Li; Guoli Li; Hanxin Lin; Jinhong Chang; Hui Zeng; Ju-Tao Guo
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

Review 8.  Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking.

Authors:  Pooyan Makvandi; Meiling Chen; Rossella Sartorius; Ali Zarrabi; Milad Ashrafizadeh; Farnaz Dabbagh Moghaddam; Jingzhi Ma; Virgilio Mattoli; Franklin R Tay
Journal:  Nano Today       Date:  2021-09-08       Impact factor: 20.722

Review 9.  Mechanisms of SARS-CoV-2 entry into cells.

Authors:  Cody B Jackson; Michael Farzan; Bing Chen; Hyeryun Choe
Journal:  Nat Rev Mol Cell Biol       Date:  2021-10-05       Impact factor: 94.444

10.  Laninamivir-Interferon Lambda 1 Combination Treatment Promotes Resistance by Influenza A Virus More Rapidly than Laninamivir Alone.

Authors:  Simone E Adams; Vladimir Y Lugovtsev; Anastasia Kan; Nicolai V Bovin; Raymond P Donnelly; Natalia A Ilyushina
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.